LD Organisation

Scientific Conference Producers

Programme


08:00

Registration

08:50

Introduction

09:00

Nexavar - A Novel Inhibitor of Signal Transduction

Dr Bernd RIEDL
BAYER PHARMA, Wuppertal, Germany
09:50

Design, Synthesis and Biological Activity of Therapeutics Targeting the PI3K Pathway

Dr. Carlos GARCIA-ECHEVERRIA
NOVARTIS PHARMA, Basel, Switzerland
10:40

Coffee-break & poster session

11:10

Discovery of Sitagliptin and Other Novel DPP4 Inhibitors

Dr Tesfaye BIFTU
MERCK, Rahway, United States
12:00

Hit-to-lead studies on Aminopropoxy phenyloxazolines. Discovery of a novel class of potent H3R ligands for the treatment of cognitive dysfunction

12:20

Sandwich lunch & posters

13:40

Dual NK3/NK1 Receptor Antagonism: A Novel Approach for the Treatment of Psychotic Disorders

Dr Patrick SCHNIDER
F. HOFFMANN-LA ROCHE, Schlieren, Switzerland
14:30

Isoindolinones as promising inhibitors of the MDM2-P53 protein-protein interaction

Dr. Eric VALEUR
MERCK SERONO, Chilly Mazarin, France
14:50

ETHR inhibitors as TB drug boosters: A new strategy to fight tuberculosis

Prof. Nicolas WILLAND
UNIVERSITY OF LILLE, Lille, France
15:10

Coffee-break & poster session

15:40

Discovery of R256918 a Gut-Selective MTP Inhibitor to Treat Obesity

Dr Lieven MEERPOEL
JOHNSON & JOHNSON PRD, Belgium
16:30

Inhibitors of Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)

Dr Mark BUNNAGE
PFIZER, Boston, United States
17:20

Closing remarks